Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Jiangsu Aidea Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥12.90 |
52 Week High | CN¥17.40 |
52 Week Low | CN¥9.63 |
Beta | 0.47 |
11 Month Change | -12.30% |
3 Month Change | -16.29% |
1 Year Change | -3.66% |
33 Year Change | -37.59% |
5 Year Change | n/a |
Change since IPO | -58.28% |
Recent News & Updates
Jiangsu Aidea Pharmaceutical (SHSE:688488) Is Making Moderate Use Of Debt
Jun 07Jiangsu Aidea Pharmaceutical Co., Ltd.'s (SHSE:688488) Shares Climb 27% But Its Business Is Yet to Catch Up
Mar 01Shareholder Returns
688488 | CN Biotechs | CN Market | |
---|---|---|---|
7D | 2.3% | -4.5% | -1.6% |
1Y | -3.7% | -20.4% | -15.7% |
Return vs Industry: 688488 exceeded the CN Biotechs industry which returned -20.4% over the past year.
Return vs Market: 688488 exceeded the CN Market which returned -15.7% over the past year.
Price Volatility
688488 volatility | |
---|---|
688488 Average Weekly Movement | 6.5% |
Biotechs Industry Average Movement | 6.2% |
Market Average Movement | 6.7% |
10% most volatile stocks in CN Market | 10.1% |
10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 688488's share price has been volatile over the past 3 months.
Volatility Over Time: 688488's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 476 | Heliang Fu | www.aidea.com.cn |
Jiangsu Aidea Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products. It offers ainuovirine tablets; urinary protein products, including crude product/intermediate of ulinastatin, urinary kallidinogenase, and urokinase; sennae folium granules; and HIV diagnostic equipment and reagents. The company was founded in 2009 and is headquartered in Yangzhou, China.
Jiangsu Aidea Pharmaceutical Co., Ltd. Fundamentals Summary
688488 fundamental statistics | |
---|---|
Market cap | CN¥5.29b |
Earnings (TTM) | -CN¥90.16m |
Revenue (TTM) | CN¥391.64m |
13.9x
P/S Ratio-60.2x
P/E RatioIs 688488 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
688488 income statement (TTM) | |
---|---|
Revenue | CN¥391.64m |
Cost of Revenue | CN¥236.14m |
Gross Profit | CN¥155.50m |
Other Expenses | CN¥245.66m |
Earnings | -CN¥90.16m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.21 |
Gross Margin | 39.70% |
Net Profit Margin | -23.02% |
Debt/Equity Ratio | 40.3% |
How did 688488 perform over the long term?
See historical performance and comparison